Looking for a product to support gut barrier function?

When is barrier function a relevant clinical consideration? The importance of an effective physical and immune barrier at the site of host-microbiome interactions cannot be downplayed. Our solution is Bio.Me™ Barrier.


When is barrier function a relevant clinical consideration?

The importance of an effective physical and immune barrier at the site of host-microbiome interactions cannot be downplayed.

Research shows us that an impaired barrier leads to a greater burden of immunomodulating substances such as lipopolysaccharides (LPS) and food proteins entering the system. This has been linked to a plethora of conditions from mental, metabolic and immune to localised gastrointestinal conditions.

And when we talk about barriers, we must consider all mucosal barriers – gut, brain, oral, lung, vaginal…

Considering this, is there ever a time when barrier function isn’t relevant in clinical practice?

Our solution: Bio.Me™ Barrier

Our barrier-specific probiotic with human clinical research to back it up.

KEY FEATURES

  • 10 billion CFU multi-species probiotic containing key Bifidobacterium, Lactobacillus and Lactococcus strains
  • Strains have been researched in vivo and in vitro
  • Strains have been researched for their compatibility to be bottled together
  • Human clinical trials using Bio.Me™ Barrier show significant results in mental health, liver cirrhosis and migraine
  • Improves markers of intestinal barrier permeability
  • Breaks down LPS
  • Stimulates IL-10
  • Non-histamine inducing
  • Probioact technology ensures stability, survival and metabolic activity
  • Doesn’t need to be refrigerated
  • Dairy-free, vegetarian, gluten-free, stevia-free, GMP, GMO-free
  • Available in 120g powder & 90 capsules

 

Buy

Related Articles


Gastrointestinal, GI EcologiX™, Immunology & Inflammation, Microbiome
Patterns of Gut Imbalance in IBD and IBS

The markers on the GI EcologiX gut health and microbiome profile were chosen because of the wealth of research and human clinical data on their relation to chronic disease. We ...

Gastrointestinal, Microbiome, Phylo Bioscience
The Lactobacillus Taxonomy Has Changed

On Wednesday the 15th of April, 2020 a new classification dividing the family of the Lactobacillaceae into Lactobacillus, Paralactobacillus, Pediococcus, and 23 novel genera was published in the International Journal of Systematic ...

Bio.Me, Bio.Me Barrier, Immunology & Inflammation, Microbiome
Probiotics and Immunity

The gut microbiota, probiotics and immunity for infectious diseases and immune health.